2021 Investor Summary


The LSX World Congress brings together leading investors from across the life sciences ecosystem including VCs, angels, HNW & private equity.

Over 400 firms and funds are represented. 

4BIO Capital
Advent Life Sciences
ALSA Ventures
Amadeus Capital Partners
Arrowfield Capital
Beiersdorf
BGV
BioCity
Bioscience Managers Pty Ltd
Breed Reply
Bridge Valley Ventures
Caixa Capital Risc
Cascara Ventures
Catapult Ventures
Clubb Capital
DeBere Capital Partners
Debiopharm Innovation Fund
Downing Ventures
Earlybird Venture Capital
Eir Ventures
Endeavour Vision
Forbion
Fountain Healthcare Partners
GEM Global Emerging Markets
GGS Associates
Hadean Ventures
HBM Partners
Health Passion Fund
HiMed Angel Fund
Human Alfa
Illumina Ventures
Industrifonden
IPF Partners
IQ Capital
Joy Ventures
Keiretsu Forum
Kissei America
Kreos Capital
Kurma Partners
LGT Lightstone
Lightstone Ventures
Livzon
Longliv Ventures
Longwall Ventures
M Ventures
Medicxi
Mercia
Mid Atlantic Bio Angels
Moonday Capital
MVM
NCL Technology Ventures
NEA
New Science Fund
New Wave Ventures
Nextech
Nina Capital
Noaber
Optum Ventures
OrbiMed
Oxford Technology Management
Panacea Venture
Peppermint Venture Partners
Pontifax
Puhua Capital
QBN Capital
Qiming Venture Partners
Quan Capital
RBV Capital
RTW Investments
RYSE Asset Management
Sanan Capital
Sanara Ventures
Seroba Life Sciences
Seventure
SHS Capital
Sofinnova Partners
SP8CEVC
Start Codon
Syncona
The Capital Partnership
Thuja Capital Management
Trilantic Europe
Triventures
Triwise Capital
Truffle Capital
TusPark UK
UCB Ventures
Unicorn Capital
University of Vermont Health Network
Ventac Partners
VI Partners
vivo capital
Wellington Partners
Wille Finance
DOWNLOAD BROCHURE